A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.Published in:British Journal of Dermatology, 2024, v. 190, n. 2, p. 216, doi. 10.1093/bjd/ljad397By:Fertitta, Laura;Bergqvist, Christina;Sarin, Kavita Y;Plotkin, Scott R;Moertel, Christopher;Petersen, Andrea K;Cannon, Ashley;Berman, Yemima;Pichard, Dominique C;Röhl, Class;Lessing, Andres;Brizion, Bernadette;Peiffer, Bastien;Ravaud, Philippe;Tran, Viet-Thi;Armand, Marie-Laure;Moryousef, Sabine;Ferkal, Salah;Jannic, Arnaud;Ezzedine, KhaledPublication type:Article